TCGG.Y Stock Overview

Provides laboratory instruments and solutions for pharmaceutical, biotechnology and in-vitro diagnostic companies, university research departments, and diagnostic and other laboratories. More details

TCGG.Y fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	1/6
Past Performance	4/6
Financial Health	5/6
Dividends	4/6

Rewards

Trading at 12.2% below our estimate of its fair value

Earnings are forecast to grow 9.45% per year

Earnings grew by 9% over the past year

Risk Analysis

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Tecan Group AG Competitors

Syneos Health

NasdaqGS:SYNH

US$4.5b

Sotera Health

NasdaqGS:SHC

US$3.9b

Stevanato Group

NYSE:STVN

US$6.5b

Bruker

NasdaqGS:BRKR

US$9.1b

Price History & Performance

Summary of share price highs, lows and changes for Tecan Group
Historical stock prices
Current Share Price	CHF 83.50
52 Week High	CHF 83.50
52 Week Low	CHF 56.93
Beta	0.64
1 Month Change	0%
3 Month Change	4.32%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-23.21%

Recent updates

Shareholder Returns

	TCGG.Y	US Life Sciences	US Market
7D	0%	1.2%	-0.2%
1Y	n/a	-1.6%	25.8%

Return vs Industry: Insufficient data to determine how TCGG.Y performed against the US Life Sciences industry.

Return vs Market: Insufficient data to determine how TCGG.Y performed against the US Market.

Price Volatility

Is TCGG.Y's price volatile compared to industry and market?
TCGG.Y volatility
TCGG.Y Average Weekly Movement	n/a
Life Sciences Industry Average Movement	9.8%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.6%
10% least volatile stocks in US Market	3.1%

Stable Share Price: TCGG.Y has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine TCGG.Y's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1980	3,444	Achim von Leoprechting	www.tecan.com

Tecan Group AG provides laboratory instruments and solutions for pharmaceutical, biotechnology and in-vitro diagnostic companies, university research departments, and diagnostic and other laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and antibodies, and software; and Tecan Labwerx, an automation solution.

Tecan Group AG Fundamentals Summary

How do Tecan Group's earnings and revenue compare to its market cap?
TCGG.Y fundamental statistics
Market cap	US$4.54b
Earnings (TTM)	US$147.32m
Revenue (TTM)	US$1.20b

30.8x

P/E Ratio

3.8x

P/S Ratio

Is TCGG.Y overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TCGG.Y income statement (TTM)
Revenue	CHF 1.07b
Cost of Revenue	CHF 683.92m
Gross Profit	CHF 390.47m
Other Expenses	CHF 258.39m
Earnings	CHF 132.08m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Aug 13, 2024

Earnings per share (EPS)	10.30
Gross Margin	36.34%
Net Profit Margin	12.29%
Debt/Equity Ratio	18.6%

How did TCGG.Y perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

29%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/06/10 14:21
End of Day Share Price	2024/03/13 00:00
Earnings	2023/12/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tecan Group AG is covered by 21 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Markus Mayer	Baader Helvea Equity Research
Volker Bosse	Baader Helvea Equity Research
Scott Bardo	Berenberg